Meta-iodobenzylguanidine uptake in platelets, megakaryoblastic leukaemia cell lines MKPL-1 and CHRF-288-11 and erythroleukaemic cell line HEL
- 31 December 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (4) , 603-606
- https://doi.org/10.1016/0959-8049(95)00058-q
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidineEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Uptake of the neuron‐blocking agent meta‐iodobenzylguanidine and serotonin by human platelets and neuro‐adrenergic tumour cellsInternational Journal of Cancer, 1993
- Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.Journal of Clinical Oncology, 1992
- Platelet serotonin transporterPublished by Elsevier ,1992
- Intracellular inhibition of mono(ADP-ribosylation) by meta-iodobenzylguanidine: specificity, intracellular concentration and effects on glucocorticoid-mediated cell lysisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- In vitro establishment and characterization of a human megakaryoblastic cell lineBlood, 1990
- HEL Cells: A New Human Erythroleukemia Cell Line with Spontaneous and Induced Globin ExpressionScience, 1982